However, some degree of heterogeneity emerged in the results concerning PCSK9-mediated LDL-C, encompassing both all types and focal epilepsy (excluding hippocampal sclerosis lesions) (Supplementary Table S4). This evidence concerns the gene PCSK9 and focal epilepsy.